Product Name

  • Name

    Valsartan

  • EINECS 1592732-453-0
  • CAS No. 137862-53-4
  • Article Data68
  • CAS DataBase
  • Density 1.212 g/cm3
  • Solubility 84.99mg/L(25 oC)
  • Melting Point 116-117 °C
  • Formula C24H29N5O3
  • Boiling Point 684.9 °C at 760 mmHg
  • Molecular Weight 435.526
  • Flash Point 368 °C
  • Transport Information
  • Appearance white crystalline powder
  • Safety 26-37/39
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 137862-53-4 (Valsartan)
  • Hazard Symbols IrritantXi
  • Synonyms L-Valine,N-(1-oxopentyl)-N-[[2'-(1H-tetrazol- 5-yl)[1,1'-biphenyl]-4-yl]methyl]-;Diovan;Diovan (TN);L-Valine, N-(1-oxopentyl)-N-((2-(1H-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-;N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine;Valsartan [USAN:INN];N-(1-n.Pentanoyl)-N-[[2'-(1H-tetrazol-5-yl)[1',1- biphenyl]-4-yl]methyl]-L-valine;Dihydrotachystero;Valsartan USP30;
  • PSA 112.07000
  • LogP 4.16170

Synthetic route

(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentarloyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine barium salt

(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentarloyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine barium salt

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With hydrogenchloride; water pH=2 - 2.5;99.9%
With hydrogenchloride In water; ethyl acetate pH=2 - 2.2; Product distribution / selectivity;
With hydrogenchloride; water In ethyl acetate pH=~ 2 - 2.5;
With hydrogenchloride In water; ethyl acetate pH=2.5 - 3.5; Product distribution / selectivity; Industry scale;
methyl N-((2’-(1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate
137863-17-3

methyl N-((2’-(1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With sodium hydroxide In diethyl ether; water at 20℃;99%
With water; sodium hydroxide In methanol at 25℃; for 12h;95%
Stage #1: methyl N-((2’-(1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate With sodium hydroxide In water at 20℃; for 20h;
Stage #2: With hydrogenchloride; water pH=2;
93%
N-[[2'-(1-triphenylmethyltetrazol-5yl)biphenyl-4-yl]methyl]-N-valeryl-L-valine methyl ester
781664-81-1

N-[[2'-(1-triphenylmethyltetrazol-5yl)biphenyl-4-yl]methyl]-N-valeryl-L-valine methyl ester

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: N-[[2'-(1-triphenylmethyltetrazol-5yl)biphenyl-4-yl]methyl]-N-valeryl-L-valine methyl ester With methanol; potassium hydroxide for 4h; Heating / reflux;
Stage #2: With water for 5h; Heating / reflux;
95%
With sodium hydroxide In methanol for 6h; Reflux;90%
C26H32N2O3

C26H32N2O3

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With sodium azide; dichloro[(-)-sparteine-N,N']copper(II) In ethyl acetate at 70 - 80℃; for 4h; Concentration; Reagent/catalyst; Large scale;92%
With sodium azide; zinc(II) chloride In N,N-dimethyl-formamide at 120 - 130℃;61%
N-pentanoyl-N-(4-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)phenyl)methyl-L-valine
783369-52-8

N-pentanoyl-N-(4-(2-(1-trityl-1H-tetrazol-5-yl)phenyl)phenyl)methyl-L-valine

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With TRILITE SCR-10 gel type In methanol for 6h; Product distribution / selectivity; Reflux;91%
With sodium hydroxide In methanol at 20℃;84%
(2S)-3-methyl-2-{N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-N'-(thiophene-2-carbonyl)-amino}-butanoic acid
1033772-60-9

(2S)-3-methyl-2-{N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-N'-(thiophene-2-carbonyl)-amino}-butanoic acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With hydrogen; nickel In methanol at 20℃; for 24h;90%
potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

A

valsartan

valsartan

B

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate With methanol for 3h; Heating / reflux;
Stage #2: In water; ethyl acetate
Stage #3: With hydrogenchloride In water Product distribution / selectivity;
A n/a
B 89%
2-(tetrazol-5'-yl)phenylboronic acid

2-(tetrazol-5'-yl)phenylboronic acid

N-(4-iodobenzyl)-N-valeryl-L-valine

N-(4-iodobenzyl)-N-valeryl-L-valine

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; N-(4-iodobenzyl)-N-valeryl-L-valine With sodium hydroxide; tetrakis(triphenylphosphine) palladium(0) In methanol; water for 2.08333h; Heating / reflux;
Stage #2: With hydrogenchloride In water pH=1 - 2; Product distribution / selectivity;
88%
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; N-(4-iodobenzyl)-N-valeryl-L-valine With sodium hydroxide; bis-triphenylphosphine-palladium(II) chloride In methanol; water at 70℃; for 3h;
Stage #2: With hydrogenchloride In water; ethyl acetate pH=1 - 2; Product distribution / selectivity;
85%
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; N-(4-iodobenzyl)-N-valeryl-L-valine With sodium methylate; 5%-palladium/activated carbon; triphenylphosphine In methanol at 70℃; for 10h;
Stage #2: With hydrogenchloride In water; ethyl acetate pH=3; Product distribution / selectivity;
71.4%
3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)but-2-enoic acid

3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)but-2-enoic acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With potassium carbonate In 5,5-dimethyl-1,3-cyclohexadiene at 100 - 120℃; for 12h; Temperature; Solvent; Reagent/catalyst;88%
sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

A

valsartan

valsartan

B

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate With methanol Heating / reflux;
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Stage #3: With hydrogenchloride In water Product distribution / selectivity;
A n/a
B 82%
N-[4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)phenyl-4-yl-methyl]-N-pentanoyl-L-valinate
943019-61-2

N-[4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)phenyl-4-yl-methyl]-N-pentanoyl-L-valinate

N-trityl-5-(2-bromophenyl)tetrazole
143945-72-6

N-trityl-5-(2-bromophenyl)tetrazole

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: N-[4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)phenyl-4-yl-methyl]-N-pentanoyl-L-valinate; N-trityl-5-(2-bromophenyl)tetrazole With potassium phosphate; palladium diacetate; triphenylphosphine In tetrahydrofuran at 60℃;
Stage #2: With methanol for 3h; Product distribution / selectivity; Heating / reflux;
77%
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine barium

N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine barium

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With hydrogenchloride In water; ethyl acetate at 25 - 35℃; Large scale reaction;77%
potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate With methanol for 3h; Heating / reflux;
Stage #2: With sodium hydrogencarbonate In water
Stage #3: With hydrogenchloride In water at 20℃; for 1h; Product distribution / selectivity;
73%
Stage #1: potassium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate With methanol for 3h; Heating / reflux;
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Stage #3: With hydrogenchloride In water Product distribution / selectivity;
66%
(S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine
137863-20-8

(S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With sodium hydroxide In water at 65℃; for 2.5h; optical yield given as %ee;72.5%
With hydrogen; 5%-palladium/activated carbon In methanol at 20℃; Product distribution / selectivity;70%
With hydrogen; 5% palladium over charcoal In methanol at 20℃; Product distribution / selectivity;70%
benzyl N-{4-[2-(1-benzyl-1H-tetrazole-5-yl)phenyl]benzyl}-N-valeryl-L-valinate

benzyl N-{4-[2-(1-benzyl-1H-tetrazole-5-yl)phenyl]benzyl}-N-valeryl-L-valinate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With 5% palladium on barium sulphate; ammonium formate In water; isopropyl alcohol at 65℃; for 11h;70.7%
3-methyl-(2S)-{pentanoyl-[2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid dilithium salt trihydrate

3-methyl-(2S)-{pentanoyl-[2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid dilithium salt trihydrate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
With hydrogenchloride; water pH=4.0 - 4.2;70%
(S)-4-isopropyl-3-pentanoyl-2-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-yl]oxazolidin-5-one
852212-82-9

(S)-4-isopropyl-3-pentanoyl-2-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-yl]oxazolidin-5-one

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: (S)-4-isopropyl-3-pentanoyl-2-[2'-(2-trityl-2H-tetrazol-5-yl)-biphenyl-4-yl]oxazolidin-5-one With ammonium formate; 5%-palladium/activated carbon In ISOPROPYLAMIDE at 90℃;
Stage #2: With sulfuric acid In tert-butyl methyl ether; ISOPROPYLAMIDE pH=2;
70%
With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran at 60℃; under 3750.38 Torr;53%
sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: sodium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate With methanol Heating / reflux;
Stage #2: With sodium hydrogencarbonate In water; ethyl acetate
Stage #3: With hydrogenchloride In water Product distribution / selectivity;
70%
2-(tetrazol-5'-yl)phenylboronic acid

2-(tetrazol-5'-yl)phenylboronic acid

(S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid
867022-57-9

(S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; (S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid With sodium hydroxide; 5%-palladium/activated carbon; trisodium tris(3-sulfophenyl)phosphine In water at 70℃; for 2h;
Stage #2: With acetic acid In water Product distribution / selectivity;
68%
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; (S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid With sodium hydroxide; tetrakis(triphenylphosphine) palladium(0) In 1,2-dimethoxyethane; ethanol; water for 12.0833h; Heating / reflux;
Stage #2: With hydrogenchloride In water pH=1 - 2; Product distribution / selectivity;
60.5%
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; (S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid With sodium methylate; 5%-palladium/activated carbon; triphenylphosphine In methanol at 70℃; for 10h;
Stage #2: With hydrogenchloride In water; ethyl acetate pH=3; Product distribution / selectivity;
58%
Stage #1: 2-(tetrazol-5'-yl)phenylboronic acid; (S)-2-[(4-bromo-benzyl)-pentanoyl-amino]-3-methyl-butyric acid With sodium methylate; triphenylphosphine; palladium dichloride In methanol at 70℃; for 5h;
Stage #2: With hydrogenchloride In water; ethyl acetate pH=1 - 2; Product distribution / selectivity;
55.6%
N-[(2'-(1-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-N-valeroyl-(L)-valine benzyl ester
137864-44-9

N-[(2'-(1-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-N-valeroyl-(L)-valine benzyl ester

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: N-[(2'-(1-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl)methyl]-N-valeroyl-(L)-valine benzyl ester In methanol for 8h; Heating / reflux;
Stage #2: With hydrogen; palladium on activated charcoal In methanol at 40℃; under 760.051 Torr; for 16h;
67%
With palladium 10% on activated carbon; hydrogen; N-ethyl-N,N-diisopropylamine In methanol under 2250.23 - 3750.38 Torr; for 6h; Autoclave;110 g
With palladium 10% on activated carbon; hydrogen; N-ethyl-N,N-diisopropylamine In methanol under 2250.23 - 3750.38 Torr; for 6h; Autoclave;110 g
Multi-step reaction with 2 steps
1.1: methanol; oxalic acid / 1.5 h / 5 - 65 °C
1.2: pH 7.5
2.1: hydrogen / palladium 10% on activated carbon / ethyl acetate / 8 - 10 h / 25 - 30 °C
View Scheme
methyl 2-(N-((2'-cyanobiphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate
137863-90-2

methyl 2-(N-((2'-cyanobiphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: methyl 2-(N-((2'-cyanobiphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate With sodium azide; zinc chloride bis(dimethylformamide) complex In N,N-dimethyl-formamide at 130 - 140℃; for 24h; Large scale;
Stage #2: With hydrogenchloride In water; N,N-dimethyl-formamide at 25 - 30℃; pH=1.5; Large scale;
Stage #3: With water; sodium hydroxide In chloroform Large scale;
66.5%
Multi-step reaction with 2 steps
1.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
1.2: 55 percent / acetic acid / toluene; H2O
2.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Stage #1: methyl 2-(N-((2'-cyanobiphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate With sodium azide; tributyltin chloride In xylene at 25℃; Heating / reflux;
Stage #2: With sodium hydroxide In water; xylene at 25 - 35℃; for 24 - 30h;
Stage #3: With acetic acid In water pH=7;
N-(5-(phenyIthio)-1-oxo-pentyI)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

N-(5-(phenyIthio)-1-oxo-pentyI)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Stage #1: N-(5-(phenyIthio)-1-oxo-pentyI)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine With sodium hydroxide; sodium tetrahydroborate; nickel dichloride In methanol; water at 0 - 5℃; for 0.333333h;
Stage #2: With acetic acid In water at 25 - 35℃; pH=5.3; Product distribution / selectivity;
46.2%
C16H15O2N

C16H15O2N

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 165.9 mg / aq. HCl / 2 h / 50 °C
2.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
2.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
3.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
4.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
4.2: 55 percent / acetic acid / toluene; H2O
5.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
N-[(2'-cyanobiphenyl-4-yl)-methyl]-(L)-valine methyl ester
137863-89-9

N-[(2'-cyanobiphenyl-4-yl)-methyl]-(L)-valine methyl ester

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
2.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
2.2: 55 percent / acetic acid / toluene; H2O
3.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: 2,6-dimethylpyridine / toluene / 2 h / 5 - 30 °C
2.1: sodium azide / toluene / 50 h / Reflux
3.1: sodium hydroxide; water / toluene / 12 h / 20 - 30 °C
3.2: pH 1 - 2.5
View Scheme
Multi-step reaction with 3 steps
1: 2,6-dimethylpyridine / water; toluene / 2 h / 5 - 30 °C
2: sodium azide / toluene / 50 h / Reflux
3: sodium hydroxide; water / toluene / 12 h / 20 - 30 °C
View Scheme
C16H13O2N
400747-06-0

C16H13O2N

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 167.9 mg / aq. HCl / 2 h / 50 °C
2.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
2.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
3.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
4.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
4.2: 55 percent / acetic acid / toluene; H2O
5.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
p-bromobenzaldehyde 1,3-dioxolane
10602-01-4

p-bromobenzaldehyde 1,3-dioxolane

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: copper(II) oxide; potassium carbonate; potassium fluoride / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
2.1: 167.9 mg / aq. HCl / 2 h / 50 °C
3.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
3.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
4.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
5.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
5.2: 55 percent / acetic acid / toluene; H2O
6.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
2-cyanobenzoic acid
3839-22-3

2-cyanobenzoic acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: 50 percent / basic copper(II) carbonate; potassium carbonate; triphenylphosphine / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
2.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
2.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
3.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
4.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
4.2: 55 percent / acetic acid / toluene; H2O
5.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 6 steps
1.1: copper(II) oxide; potassium carbonate; potassium fluoride / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
2.1: 167.9 mg / aq. HCl / 2 h / 50 °C
3.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
3.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
4.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
5.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
5.2: 55 percent / acetic acid / toluene; H2O
6.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 6 steps
1.1: copper(II) oxide; potassium carbonate; potassium fluoride / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
2.1: 165.9 mg / aq. HCl / 2 h / 50 °C
3.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
3.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
4.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
5.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
5.2: 55 percent / acetic acid / toluene; H2O
6.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
ammonium 2-(aminocarbonyl)benzoate
131-63-5

ammonium 2-(aminocarbonyl)benzoate

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 72 percent / acetic anhydride; pyridine
2.1: 50 percent / basic copper(II) carbonate; potassium carbonate; triphenylphosphine / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
3.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
3.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
4.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
5.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
5.2: 55 percent / acetic acid / toluene; H2O
6.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 7 steps
1.1: 72 percent / acetic anhydride; pyridine
2.1: copper(II) oxide; potassium carbonate; potassium fluoride / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
3.1: 167.9 mg / aq. HCl / 2 h / 50 °C
4.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
4.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
5.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
6.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
6.2: 55 percent / acetic acid / toluene; H2O
7.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 7 steps
1.1: 72 percent / acetic anhydride; pyridine
2.1: copper(II) oxide; potassium carbonate; potassium fluoride / palladium(II) bromide; 1,10-phenanthroline / quinoline / 24 h / 170 °C
3.1: 165.9 mg / aq. HCl / 2 h / 50 °C
4.1: molecular sieves 3 Angstroem / tetrahydrofuran / 60 h / 20 °C
4.2: 90 percent / sodium cyanoborohydride / tetrahydrofuran; ethanol / 24 h / 23 °C
5.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
6.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
6.2: 55 percent / acetic acid / toluene; H2O
7.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
n-valeryl chloride
638-29-9

n-valeryl chloride

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: 98 percent / pyridine / CH2Cl2 / 2 h / 40 °C
2.1: sodium azide; tri-n-butyltin chloride; tetrabutylammonium bromide / toluene / 72 h / Heating
2.2: 55 percent / acetic acid / toluene; H2O
3.1: 99 percent / NaOH / diethyl ether; H2O / 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: potassium carbonate / dichloromethane / 5.5 h / 0 - 5 °C
2.1: sodium azide; zinc(II) chloride / diethylene glycol dimethyl ether / 26 h / 120 °C
3.1: sodium hydroxide / water / 4 h / 40 °C
3.2: pH 1.5 - 2 / Cooling; Acidic conditions
View Scheme
Multi-step reaction with 3 steps
1.1: potassium carbonate / dichloromethane / 5.5 h / 0 - 5 °C
2.1: sodium azide; zinc(II) chloride / diethylene glycol dimethyl ether / 24 h / 120 °C
3.1: sodium hydroxide / water / 4 h / 40 °C
3.2: pH 1.5 - 2 / Cooling; Acidic conditions
View Scheme
trityl chloride
76-83-5

trityl chloride

triethylamine
121-44-8

triethylamine

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

triethylammonium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

triethylammonium N-pentanoyl-N-[{2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl}methyl]-L-valinate

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 5h; Product distribution / selectivity;100%
N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C24H28(3)HN5O3

C24H28(3)HN5O3

Conditions
ConditionsYield
With tritium; η4-cycloocta-1,5-diene(1,3-dimesitylimidazoline-2-ylidene)(triphenylphosphine)iridium(I) tetrakis[(3,5-trifluoromethylphenyl)]borate; caesium carbonate In methanol at 20 - 50℃; for 3.25h;98.9%
N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

magnesium-valsartan-hexahydrate

magnesium-valsartan-hexahydrate

Conditions
ConditionsYield
With water; magnesium oxide In ethanol at 20 - 40℃; pH=4 - 7.5;95%
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid

4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

Conditions
ConditionsYield
With sodium hydroxide In methanol; water at 15 - 35℃; for 1h; Solvent; Temperature;94.23%
2-(N,N-dimethylamino)ethanol
108-01-0

2-(N,N-dimethylamino)ethanol

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C28H38N6O3

C28H38N6O3

Conditions
ConditionsYield
With thionyl chloride In dichloromethane for 1h; Reflux;93.1%
2-(Diethylamino)ethanol
100-37-8

2-(Diethylamino)ethanol

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C30H42N6O3

C30H42N6O3

Conditions
ConditionsYield
With thionyl chloride In dichloromethane for 1h; Reflux;92.5%
N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenyl-methyl)-4-amino-(2R)-methylbutanoic acid ethyl ester calcium salt

N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenyl-methyl)-4-amino-(2R)-methylbutanoic acid ethyl ester calcium salt

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

trisodium [3-((1S,3R)-1-biphenyl-4-yl-methyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-yl-methyl}amino)butyrate] hemipentahydrate
936623-90-4

trisodium [3-((1S,3R)-1-biphenyl-4-yl-methyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-yl-methyl}amino)butyrate] hemipentahydrate

Conditions
ConditionsYield
Stage #1: N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenyl-methyl)-4-amino-(2R)-methylbutanoic acid ethyl ester calcium salt With hydrogenchloride; water In Isopropyl acetate
Stage #2: N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine With sodium hydroxide In n-heptane; water; acetone at 45℃; Temperature;
91.9%
N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine disodium salt

(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine disodium salt

Conditions
ConditionsYield
With sodium hydroxide In water; acetone at 25 - 35℃; for 5h;91.66%
With sodium carbonate In water; acetone for 3h; Reflux;
With sodium hydroxide In ethanol
α-ethyl (αR,γS)-γ-<(3-carboxy-1-oxopropyl)amino>-α-methyl<1,1'-biphenyl>-4-pentanoate monosodium salt
149690-05-1

α-ethyl (αR,γS)-γ-<(3-carboxy-1-oxopropyl)amino>-α-methyl<1,1'-biphenyl>-4-pentanoate monosodium salt

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

Conditions
ConditionsYield
With sodium hydroxide In Isopropyl acetate; water; acetonitrile at 40 - 65℃;91%
Stage #1: N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine With sodium hydroxide In methanol at 25 - 35℃; for 0.5h;
Stage #2: α-ethyl (αR,γS)-γ-<(3-carboxy-1-oxopropyl)amino>-α-methyl<1,1'-biphenyl>-4-pentanoate monosodium salt In acetone at 25 - 35℃; for 0.166667h; Solvent;
6.3 g
(2R,4S)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester dicyclohexylamine salt

(2R,4S)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester dicyclohexylamine salt

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

LCZ696

LCZ696

Conditions
ConditionsYield
With sodium hydroxide In Isopropyl acetate; water; acetone at 25 - 55℃; for 4.5h; Solvent; Temperature;91%
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid

4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

trisodium [3-((1S,3R)-1-biphenyl-4-yl-methyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-yl-methyl}amino)butyrate] hemipentahydrate
936623-90-4

trisodium [3-((1S,3R)-1-biphenyl-4-yl-methyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-yl-methyl}amino)butyrate] hemipentahydrate

Conditions
ConditionsYield
With sodium hydroxide In water; acetone at 25 - 35℃; for 1h;90.83%
N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C24H28(2)HN5O3

C24H28(2)HN5O3

Conditions
ConditionsYield
With η4-cycloocta-1,5-diene(1,3-dimesitylimidazoline-2-ylidene)(triphenylphosphine)iridium(I) tetrakis[(3,5-trifluoromethylphenyl)]borate; water-d2; caesium carbonate In methanol at 50℃; for 6h;88%
C24H30N2O5

C24H30N2O5

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C47H54N7O8(2-)*3Na(1+)*2.5H2O

C47H54N7O8(2-)*3Na(1+)*2.5H2O

Conditions
ConditionsYield
With water; sodium hydroxide In acetone at 20℃; for 2h;87%
C26H34N2O5

C26H34N2O5

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C49H58N7O8(2-)*3Na(1+)*2.5H2O

C49H58N7O8(2-)*3Na(1+)*2.5H2O

Conditions
ConditionsYield
With water; sodium hydroxide In acetone for 2h;85.6%
3C24H28NO5(1-)*3Na(1+)*C24H29NO5*2C2H4O2

3C24H28NO5(1-)*3Na(1+)*C24H29NO5*2C2H4O2

water
7732-18-5

water

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C24H28NO5(1-)*C24H28N5O3(1-)*2Na(1+)*2.5H2O

C24H28NO5(1-)*C24H28N5O3(1-)*2Na(1+)*2.5H2O

Conditions
ConditionsYield
With sodium hydroxide In Isopropyl acetate; acetone at 40 - 45℃; for 2h;85%
C28H38N2O5

C28H38N2O5

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C51H62N7O8(2-)*3Na(1+)*2.5H2O

C51H62N7O8(2-)*3Na(1+)*2.5H2O

Conditions
ConditionsYield
With water; sodium hydroxide In acetone for 2h;84.2%
methanol
67-56-1

methanol

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

methyl N-((2’-(1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate
137863-17-3

methyl N-((2’-(1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate

Conditions
ConditionsYield
With thionyl chloride at 0 - 25℃; for 4.5h;83%
With thionyl chloride at 4 - 20℃; for 3h;
C30H42N2O5

C30H42N2O5

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

C53H66N7O8(2-)*3Na(1+)*2.5H2O

C53H66N7O8(2-)*3Na(1+)*2.5H2O

Conditions
ConditionsYield
With water; sodium hydroxide In acetone for 3.5h;82.2%
(2R,4S)-5-biphenyl-4-yl-4-(3-carboxypropionylamino)-2-methylpentanoic acid ethyl ester 1-(naphthalen-1-yl)ethan-1-amine salt

(2R,4S)-5-biphenyl-4-yl-4-(3-carboxypropionylamino)-2-methylpentanoic acid ethyl ester 1-(naphthalen-1-yl)ethan-1-amine salt

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine
137862-53-4

N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3’-methyl-2’-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4’-ylmethyl}amino)butyrate]hemipentahydrate

Conditions
ConditionsYield
Stage #1: (2R,4S)-5-biphenyl-4-yl-4-(3-carboxypropionylamino)-2-methylpentanoic acid ethyl ester 1-(naphthalen-1-yl)ethan-1-amine salt; N-pentanoyl-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-(L)-valine In acetone at 10℃;
Stage #2: With sodium hydroxide In water; acetone
80%

Valsartan Chemical Properties

Structure of Valsartan (CAS NO.137862-53-4):

IUPAC Name: (2S)-3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
Molecular Formula: C24H29N5O3
Molar mass: 435.5188 g/mol
Density: 1.212 g/cm3
Flash Point: 368 °C
Index of Refraction: 1.586
Boiling Point: 684.9 °C at 760 mmHg
Vapour Pressure: 1.06E-19 mmHg at 25 °C
Melting Point: 116-117 °C
Appearance: white crystalline powder
XLogP3-AA: 4.4
H-Bond Donor: 2
H-Bond Acceptor: 6
Rotatable Bond Count: 10
Tautomer Count: 2
Exact Mass: 435.22704
MonoIsotopic Mass: 435.22704
Topological Polar Surface Area: 112
Heavy Atom Count: 32 
Canonical SMILES: CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
Isomeric SMILES: CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
InChI: InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1
InChIKey: ACWBQPMHZXGDFX-QFIPXVFZSA-N
Product Categories: Active Pharmaceutical Ingredients; Antihypertensive; APIs; Intermediates & Fine Chemicals; Pharmaceuticals; API's         

Valsartan Uses

 Valsartan (CAS NO.137862-53-4) is indicated for treatment of high blood pressure, congestive heart failure (CHF), or post-myocardial infarction (MI) in the U.S.. A study released by the Journal of Clinical Investigation in 2007 found some efficacy in the use of valsartan in the treatment and prevention of Alzheimer's Disease although such use is considered to be highly experimental.

Valsartan Safety Profile

Hazard Codes: IrritantXi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-37/39
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S37/39:Wear suitable gloves and eye/face protection.

Valsartan Specification

 Valsartan (CAS NO.137862-53-4) is also named as CGP 48933 ; Diovan ; HSDB 7519 ; UNII-80M03YXJ7I ; Valtan ; Valzaar ; L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- ; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine . It is an angiotensin II receptor antagonist (more commonly called an "ARB", which stands for angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View